Allogene Therapeutics, Inc. - COM (ALLO)

Q4 2018 13F Holders as of 12/31/2018

Type / Class
Equity / COM
Number of holders
79
Total Shares
55M
Shares change
+55M
Total reported value, excl. options
$1.47B
Value change
+$1.47B
Put/Call ratio
0
Number of buys
78
Number of sells
0
Price
$26.93
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.